Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -61.03% is 30% above its 5-year average of -87.38%, near the high end of its 5-year range (-239.44%–-22.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.90% above its 12-month average of -73.44%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -61.03%.
RETURN ON INVESTED CAPITAL (ROIC)
-61.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-73.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-107.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-87.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-75.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.90%
CURRENT VS 3Y AVG
+43.02%
CURRENT VS 5Y AVG
+30.16%
CURRENT VS 10Y AVG
+19.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-71.21%
vs the sector median at left
Profound Medical Corp.
Market Cap
$222.75M
Return on Invested Capital (ROIC)
-61.03%
TTM Avg
-73.44%
3Y Avg
-107.11%
5Y Avg
-87.38%
Market Cap
$222.46M
Return on Invested Capital (ROIC)
-36.49%
TTM Avg
-7.39%
3Y Avg
-25.88%
5Y Avg
-24.07%
Market Cap
$228.33M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$230.47M
Return on Invested Capital (ROIC)
-25.73%
TTM Avg
-40.62%
3Y Avg
-54.07%
5Y Avg
-54.31%
Market Cap
$214.42M
Return on Invested Capital (ROIC)
8.84%
TTM Avg
15.21%
3Y Avg
-9.34%
5Y Avg
-32.56%
Market Cap
$231.50M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-43.46%
3Y Avg
-51.45%
5Y Avg
-53.92%
Market Cap
$213.50M
Return on Invested Capital (ROIC)
-43.74%
TTM Avg
-105.81%
3Y Avg
-81.36%
5Y Avg
-65.49%
Market Cap
$215.51M
Return on Invested Capital (ROIC)
19.13%
TTM Avg
15.37%
3Y Avg
31.31%
5Y Avg
44.42%
Market Cap
$213.19M
Return on Invested Capital (ROIC)
-70.80%
TTM Avg
-76.09%
3Y Avg
-51.87%
5Y Avg
-42.00%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profound Medical Corp. (PROF) | $222.75M | -61.03% | -73.44% | -107.11% | -87.38% |
| Keros Therapeutics, Inc. (KROS)vs › | $222.46M | -36.49% | -7.39% | -25.88% | -24.07% |
| Vogenx Inc. (VOGX)vs › | $228.33M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $230.47M | -25.73% | -40.62% | -54.07% | -54.31% |
| Niagen Bioscience Inc (NAGE)vs › | $214.42M | 8.84% | 15.21% | -9.34% | -32.56% |
| MacroGenics, Inc. (MGNX)vs › | $231.50M | -16.87% | -43.46% | -51.45% | -53.92% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $213.50M | -43.74% | -105.81% | -81.36% | -65.49% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $215.51M | 19.13% | 15.37% | 31.31% | 44.42% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $213.19M | -70.80% | -76.09% | -51.87% | -42.00% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $233.51M | -40.52% | -35.57% | -28.84% | -24.57% |
ROIC
-61.0%
ROE
-65.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -61.03% |
| 2026-03-31 | -56.18% |
| 2025-12-31 | -22.31% |
| 2025-09-30 | -128.64% |
| 2025-06-30 | -99.06% |
| 2025-03-31 | -67.60% |
| 2024-12-31 | -52.40% |
| 2024-09-30 | -239.44% |
| 2024-06-30 | -136.20% |
| 2024-03-31 | -100.15% |
| 2023-12-31 | -135.41% |
| 2023-09-30 | -173.83% |
| 2023-06-30 | -120.20% |
| 2023-03-31 | -136.32% |
| 2022-12-31 | -102.14% |
| 2022-09-30 | -83.71% |
| 2022-06-30 | -76.02% |
| 2022-03-31 | -67.79% |
| 2021-12-31 | -63.73% |
| 2021-09-30 | -26.49% |
| 2021-06-30 | -38.40% |
| 2021-03-31 | -33.44% |
| 2020-12-31 | -40.94% |
| 2020-09-30 | -7.26% |
| 2020-06-30 | -19.74% |
| 2020-03-31 | -20.45% |
| 2019-12-31 | -30.34% |
| 2019-09-30 | -39.45% |
| 2019-06-30 | -38.68% |
| 2019-03-31 | -33.80% |
| 2018-12-31 | -36.96% |
| 2018-09-30 | -34.16% |
| 2018-06-30 | -54.25% |
| 2018-03-31 | -34.61% |
| 2017-12-31 | -90.13% |
| 2017-09-30 | -82.92% |
| 2017-06-30 | -163.82% |
| 2017-03-31 | -111.45% |
| 2016-12-31 | -98.65% |
| 2016-09-30 | -186.13% |
| 2016-06-30 | -121.85% |
| 2016-03-31 | -108.77% |
| 2015-12-31 | -88.34% |
| 2015-09-30 | -71.83% |
| 2015-06-30 | -48.62% |
| 2014-12-31 | -328.25% |
